#startup of the day 5 - PrecizionIQ Data Private Limited

Inception - September 5, 2022

Location - Gurugram, Haryana

Industry domain -  PrecizionIQ is a precision diagnostics company developing affordable, biomarker-driven, metabolomics-based diagnostic solutions for early disease detection. The company is making advanced diagnostics accessible to all, with a current focus on prenatal chromosomal abnormalities and preeclampsia.

Founders - Dr. Murli Manohar, Dr. Pedro Rodrigues, Dr. Kamal Tyagi, Amit Kumar, and Anurag Dikshit

Total team strength - 5 core team members

Total funds raised - $210,000

Investors - Pre-Seed funding of $210,000 secured from a US-based angel investor.

Revenue generated since inception - PrecizionIQ is currently in the pre-revenue stage, focusing on research and development, clinical validation, and regulatory groundwork.

Key Highlights - 

1.  Golden Ticket at Bharat Ke Super Founders: Awarded a Golden Ticket entry at the PanIIT Bangalore Summit 2026 for Season 2 of Bharat Ke Super Founders (Amazon Prime).
    2.  PCT Patent Filed: Filed a Patent Cooperation Treaty (PCT) application for a novel metabolomics-based diagnostic methodology for early detection of prenatal chromosomal abnormalities.
    3.  Pre-Seed Funding Secured: Successfully raised $210,000 from a US-based investor to support the development of affordable diagnostic tools.
    4.  Bharat Innovates 2026: Advanced to the second round of evaluation at IIT Gandhinagar.

Founder Speaks - 

Our near-term goal is to commercialize affordable biomarker-based diagnostic solutions for prenatal chromosomal abnormalities and preeclampsia. Looking ahead, we plan to expand our platform into other domains, such as cancer, through strategic partnerships and clinical validation, with the long-term vision of building a globally recognized precision diagnostics platform.

- Dr. Murli Manohar, Dr. Pedro Rodrigues, Dr. Kamal Tyagi, Amit Kumar, and Anurag Dikshit